The fine line between familial and polygenic hypercholesterolemia-Reference-Cited by-同舟云学术

The fine line between familial and polygenic hypercholesterolemia

Published:2013-06-01 Issue:3 Volume:8 Page:303-306
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Castro–Orós Isabel De¹,Pocoví Miguel²,Civeira Fernando³

Affiliation:

1. Laboratorio de Investigación Molecular, Hospital Universitario Miguel Servet, Instituto Aragones de Ciencias de Salud. Departamento de Bioquímica, Biología Molecular y Celular. Universidad de Zaragoza, Avda Isabel La Católica 1-3, 50009, Zaragoza, Spain

2. Departamento de Bioquímica, Biología Molecular y Celular. Universidad de Zaragoza, Ciudad Universitaria, 50009, Zaragoza, Spain

3. Unidad de Lípidos & Laboratorio de Investigación Molecular, Hospital Universitario Miguel Servet, Instituto Aragonés de Ciencias de Salud. Universidad de Zaragoza, Avda Isabel La Católica 1-3, 50009, Zaragoza, Spain

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.13.20

Reference18 articles.

1. Goldstein J, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS et al. (Eds). Mc Graw-Hill, NY, USA, 2863–2913 (2001).

2. Scientific Steering Committee on behalf of the Simon Broome Register Group: risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 303(6807), 893–896 (1991).

3. Civeira F; International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173(1), 55–68 (2004). International expert panel position on the definition, diagnosis and treatment of familial hypercholesterolemia.

4. Civeira F, Ros E, Jarauta E et al. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am. J. Cardiol. 102(9), 1187–1193 (2008).

5. Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307), 707–713 (2010). Authors screened the genome for common variants associated with plasma lipids in >100,000 individuals of European ancestry. They report 95 loci with genome-wide significant association with lipids.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning modelling of blood lipid biomarkers in familial hypercholesterolaemia versus polygenic/environmental dyslipidaemia;Scientific Reports;2021-02-15

2. Genetic determinants of inherited susceptibility to hypercholesterolemia – a comprehensive literature review;Lipids in Health and Disease;2017-06-02

3. Rare genetic variants with large effect on triglycerides in subjects with a clinical diagnosis of familial vs nonfamilial hypertriglyceridemia;Journal of Clinical Lipidology;2016-07

4. Necesidades no cubiertas: pacientes intolerantes a las estatinas y pacientes con hipercolesterolemia familiar;Clínica e Investigación en Arteriosclerosis;2016-05

5. La lipoproteína(a) se asocia a la presencia de arteriosclerosis en pacientes con hipercolesterolemia primaria;Clínica e Investigación en Arteriosclerosis;2014-07